Search Tag: hypertriglyceridaemia

2025 30 Aug

A new ESC/EAS Focused Update on lipid management, released at ESC Congress 2025, provides fresh guidance on how best to reduce cardiovascular risk in patients. Central to the update is the recommendation to use new cardiovascular risk prediction algorithms, designed to help clinicians make more precise treatment decisions.   The algorithms, 1Read more

2024 09 Apr

  Elevated levels of lipids in the bloodstream (hypertriglyceridaemia) increase the risk of heart attack, stroke, and acute pancreatitis. Current medications, such as statins, ezetimibe, fibrates, and prescription omega-3 fatty acids, typically lower triglyceride levels by varying degrees, ranging from below 10% to up to 40%. While these treatme1Read more

2023 05 Apr

Elevated triglyceride levels are linked to a higher risk of cardiovascular events. However, it is unclear if lowering triglyceride levels would reduce cardiovascular risk.   Pemafibrate, a medication that selectively modulates a receptor called peroxisome proliferator-activated receptor α, can lower triglyceride levels and improve other lipid 1Read more